Compare key investment metrics of 삼진제약 and 464280 in real time. Both stocks belong to the 진통제 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- On earnings-based valuation, 464280 trades at a lower PER — 6.72x vs 삼진제약's 11.56x. A lower PER can suggest undervaluation, but differences in growth expectations should also be considered.
- By market capitalization, 삼진제약 is larger — ₩246B vs 464280's ₩34B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 삼진제약's current price of 18,430원 sits at about 15% of its 52-week range (16,990원–26,400원).
- 464280's current price of 6,140원 sits at about 11% of its 52-week range (5,430원–11,690원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 삼진제약 | 464280 |
|---|---|---|
| Price | 18,430원 | 6,140원 |
| PER | 11.56배 | 6.72배 |
| PBR | 0.84배 | 0.74배 |
| Dividend Yield | 4.34% | - |
| Market Cap | ₩246B | ₩34B |
| 52-Week High | 26,400원 | 11,690원 |
| 52-Week Low | 16,990원 | 5,430원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 삼진제약 or 464280?
As of 2026-07-06, 464280 has the lower PER — about 6.72x vs 삼진제약's 11.56x. PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share; a lower PER may suggest undervaluation, but growth expectations should also be considered.
What is the dividend yield difference between 삼진제약 and 464280?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 삼진제약 and 464280 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 삼진제약 and 464280?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.